A Novel Somatic Variant in HEY2 Unveils an Alternative Splicing Isoform Linked to Ventricular Septal Defect

Manal Fardoun, Hassan Dehaini, Amina Kamar, Fadi Bitar, Marianne Majdalani, Issam El-Rassi, Georges Nemer, Mariam Arabi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Congenital heart defects (CHDs) are the leading cause of death in infants under 1 year of age. Aberrations in the expression and function of cardiac transcription factors (TFs) are a major contributor to CHDs. Despite the numerous studies undertaken to functionally characterize these TFs, their exact role in different stages of cardiogenesis is still not fully elucidated. Here we focused on HEY2, a basic helix loop helix transcriptional repressor, and its potential role in human ventricular septal defects. Genetic analysis was performed based on sequencing of DNA and cDNA obtained from post-operational cardiac tissues and blood of 17 Lebanese patients with various CHDs. The screen covered the entire coding regions of the GATA4, NKX2.5, TBX5, TBX20 and HEY2 genes. Our results revealed two novel somatic mutations, namely p.Ala229Thr and p.161_190 del, affecting HEY2 in the diseased cardiac tissues of two patients with VSD. These results suggest a potential role of HEY2 in regulating ventricular septation in humans.

Original languageEnglish
Pages (from-to)1084-1091
Number of pages8
JournalPediatric Cardiology
Volume40
Issue number5
DOIs
Publication statusPublished - 15 Jun 2019
Externally publishedYes

Keywords

  • Cardiac transcription factors
  • Congenital heart defects
  • HEY2
  • Mutation
  • Ventricular septal defect

Fingerprint

Dive into the research topics of 'A Novel Somatic Variant in HEY2 Unveils an Alternative Splicing Isoform Linked to Ventricular Septal Defect'. Together they form a unique fingerprint.

Cite this